ATE330030T1 - Eine familie von genen mit transformationsmodulierender aktivität - Google Patents

Eine familie von genen mit transformationsmodulierender aktivität

Info

Publication number
ATE330030T1
ATE330030T1 AT98962084T AT98962084T ATE330030T1 AT E330030 T1 ATE330030 T1 AT E330030T1 AT 98962084 T AT98962084 T AT 98962084T AT 98962084 T AT98962084 T AT 98962084T AT E330030 T1 ATE330030 T1 AT E330030T1
Authority
AT
Austria
Prior art keywords
transformation
normal
cancer
prostate
sequence changes
Prior art date
Application number
AT98962084T
Other languages
English (en)
Inventor
Gary R Pasternack
Gerald J Kocheavar
Jonathan R Brody
Shrihari S Kadkol
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE330030T1 publication Critical patent/ATE330030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98962084T 1997-12-12 1998-12-11 Eine familie von genen mit transformationsmodulierender aktivität ATE330030T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6967797P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
ATE330030T1 true ATE330030T1 (de) 2006-07-15

Family

ID=22090529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962084T ATE330030T1 (de) 1997-12-12 1998-12-11 Eine familie von genen mit transformationsmodulierender aktivität

Country Status (7)

Country Link
EP (1) EP1045926B1 (de)
JP (1) JP2002508154A (de)
AT (1) ATE330030T1 (de)
AU (1) AU1724699A (de)
CA (1) CA2311645A1 (de)
DE (1) DE69834951T2 (de)
WO (1) WO1999029906A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930175B1 (en) 1997-12-12 2005-08-16 The Johns Hopkins University School Of Medicine Gene family with transformation modulating activity
EP1146909A4 (de) * 1999-02-03 2004-12-29 Univ Johns Hopkins Verfahren zur behandlung von krebs mittels wiederherstellung der pp32-funktion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734022A (en) * 1990-08-01 1998-03-31 The Johns Hopkins University Antibodies to a novel mammalian protein associated with uncontrolled cell division
GB9216851D0 (en) * 1992-08-07 1992-09-23 Univ Manitoba Dna sequences of rat probasin gene

Also Published As

Publication number Publication date
EP1045926B1 (de) 2006-06-14
EP1045926A2 (de) 2000-10-25
DE69834951D1 (de) 2006-07-27
WO1999029906A3 (en) 1999-08-26
DE69834951T2 (de) 2007-02-08
CA2311645A1 (en) 1999-06-17
JP2002508154A (ja) 2002-03-19
AU1724699A (en) 1999-06-28
WO1999029906A2 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
BR0113491A (pt) Polinucleotìdeo e polipeptìdeo isolados, vetor de expressão, célula hospedeira, proteìna de fusão, métodos para estimular e/ou expandir células t especìficas para uma protéina de tumor, para estimular uma resposta imune em um paciente, para o tratamento de um câncer em um paciente e para inibir o desenvolvimento de um câncer em um paciente, população de célula t isolada, composição, e, uso de um componente.
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
MXPA02000192A (es) Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.
DE60135315D1 (de) In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide
DE69534946D1 (de) Verwendung von nackten Polynukleotiden zur Herstellung eines Medikaments für die Behandlung von Tumoren
Miyake et al. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential
ATE241375T1 (de) Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata
WO2001072295A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
MX9708401A (es) Genes reguladores de la cromatina.
WO2002004514A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1455840A4 (de) Behandlung von krebs bei menschen mit adenovirus-vektor tnf-alpha
ATE330030T1 (de) Eine familie von genen mit transformationsmodulierender aktivität
NO308396B1 (no) FremgangsmÕte ved fremstilling av substanser av polypeptidnatur
BR9707994A (pt) Adenovírus recombinantes defectivo composição farmacêutica utilização do adenovirus composição e processo de preparação de células t citotóxicas especificas de um antigene tumoral
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
ATE285247T1 (de) Krebstherapie mit lymphotoxin
TR200101141T2 (tr) Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
ATE504309T1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
WO2002000174A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001072341A3 (en) Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
WO2002045657A3 (en) Ovarian tumor antigen and methods of use therefor
EP1351967A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties